BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18162312)

  • 1. A dysbindin risk haplotype associated with less severe manic-type symptoms in psychosis.
    Corvin A; Donohoe G; Nangle JM; Schwaiger S; Morris D; Gill M
    Neurosci Lett; 2008 Jan; 431(2):146-9. PubMed ID: 18162312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis.
    Kishimoto M; Ujike H; Motohashi Y; Tanaka Y; Okahisa Y; Kotaka T; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Biol Psychiatry; 2008 Jan; 63(2):191-6. PubMed ID: 17555717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early visual processing deficits in dysbindin-associated schizophrenia.
    Donohoe G; Morris DW; De Sanctis P; Magno E; Montesi JL; Garavan HP; Robertson IH; Javitt DC; Gill M; Corvin AP; Foxe JJ
    Biol Psychiatry; 2008 Mar; 63(5):484-9. PubMed ID: 17945199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DTNBP1 haplotype influences baseline assessment scores of schizophrenic in-patients.
    Pae CU; Drago A; Kim JJ; Patkar AA; Jun TY; Lee C; Mandelli L; De Ronchi D; Paik IH; Serretti A
    Neurosci Lett; 2008 Aug; 440(2):150-4. PubMed ID: 18562100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbindin gene variants are associated with bipolar I disorder in a Korean population.
    Joo EJ; Lee KY; Jeong SH; Chang JS; Ahn YM; Koo YJ; Kim YS
    Neurosci Lett; 2007 May; 418(3):272-5. PubMed ID: 17433541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).
    Williams NM; Preece A; Morris DW; Spurlock G; Bray NJ; Stephens M; Norton N; Williams H; Clement M; Dwyer S; Curran C; Wilkinson J; Moskvina V; Waddington JL; Gill M; Corvin AP; Zammit S; Kirov G; Owen MJ; O'Donovan MC
    Arch Gen Psychiatry; 2004 Apr; 61(4):336-44. PubMed ID: 15066891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbindin and d-amino-acid-oxidase gene polymorphisms associated with positive and negative symptoms in schizophrenia.
    Wirgenes KV; Djurovic S; Agartz I; Jonsson EG; Werge T; Melle I; Andreassen OA
    Neuropsychobiology; 2009; 60(1):31-6. PubMed ID: 19729970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study.
    Donohoe G; Morris DW; Clarke S; McGhee KA; Schwaiger S; Nangle JM; Garavan H; Robertson IH; Gill M; Corvin A
    Neuropsychologia; 2007 Jan; 45(2):454-8. PubMed ID: 16930638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia.
    Corvin A; Donohoe G; McGhee K; Murphy K; Kenny N; Schwaiger S; Nangle JM; Morris D; Gill M
    Neurosci Lett; 2007 Oct; 426(2):97-100. PubMed ID: 17890006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysbindin C-A-T haplotype is associated with thicker medial orbitofrontal cortex in healthy population.
    Cerasa A; Quattrone A; Gioia MC; Tarantino P; Annesi G; Assogna F; Caltagirone C; De Luca V; Spalletta G
    Neuroimage; 2011 Mar; 55(2):508-13. PubMed ID: 21184829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dysbindin gene (DTNBP1) and schizophrenia: no support for an association in the Korean population.
    Joo EJ; Lee KY; Jeong SH; Ahn YM; Koo YJ; Kim YS
    Neurosci Lett; 2006 Oct; 407(2):101-6. PubMed ID: 16959423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysbindin modulates brain function during visual processing in children.
    Mechelli A; Viding E; Kumar A; Pettersson-Yeo W; Fusar-Poli P; Tognin S; O'Donovan MC; McGuire P
    Neuroimage; 2010 Jan; 49(1):817-22. PubMed ID: 19631276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder.
    Schumacher J; Jamra RA; Freudenberg J; Becker T; Ohlraun S; Otte AC; Tullius M; Kovalenko S; Bogaert AV; Maier W; Rietschel M; Propping P; Nöthen MM; Cichon S
    Mol Psychiatry; 2004 Feb; 9(2):203-7. PubMed ID: 14966479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population.
    Tochigi M; Zhang X; Ohashi J; Hibino H; Otowa T; Rogers M; Kato T; Okazaki Y; Kato N; Tokunaga K; Sasaki T
    Neurosci Res; 2006 Oct; 56(2):154-8. PubMed ID: 16876895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments.
    Palo OM; Antila M; Silander K; Hennah W; Kilpinen H; Soronen P; Tuulio-Henriksson A; Kieseppä T; Partonen T; Lönnqvist J; Peltonen L; Paunio T
    Hum Mol Genet; 2007 Oct; 16(20):2517-28. PubMed ID: 17673452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operation of the schizophrenia susceptibility gene, neuregulin 1, across traditional diagnostic boundaries to increase risk for bipolar disorder.
    Green EK; Raybould R; Macgregor S; Gordon-Smith K; Heron J; Hyde S; Grozeva D; Hamshere M; Williams N; Owen MJ; O'Donovan MC; Jones L; Jones I; Kirov G; Craddock N
    Arch Gen Psychiatry; 2005 Jun; 62(6):642-8. PubMed ID: 15939841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression.
    Bray NJ; Preece A; Williams NM; Moskvina V; Buckland PR; Owen MJ; O'Donovan MC
    Hum Mol Genet; 2005 Jul; 14(14):1947-54. PubMed ID: 15917270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS).
    Gaysina D; Cohen-Woods S; Chow PC; Martucci L; Schosser A; Ball HA; Tozzi F; Perry J; Muglia P; Craig IW; McGuffin P; Farmer A
    Am J Med Genet B Neuropsychiatr Genet; 2009 Sep; 150B(6):836-44. PubMed ID: 19089808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia.
    Fanous AH; van den Oord EJ; Riley BP; Aggen SH; Neale MC; O'Neill FA; Walsh D; Kendler KS
    Am J Psychiatry; 2005 Oct; 162(10):1824-32. PubMed ID: 16199828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls.
    Hashimoto R; Noguchi H; Hori H; Nakabayashi T; Suzuki T; Iwata N; Ozaki N; Kosuga A; Tatsumi M; Kamijima K; Harada S; Takeda M; Saitoh O; Kunugi H
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):431-8. PubMed ID: 19353385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.